Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. (Q43127349)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 March 2010

Language	Label	Description	Also known as
English	Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.	scientific article published on 16 March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

François-Clément Bidard

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

C Mathiot

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Degeorges

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M-C Etienne-Grimaldi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

R Delva

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Veyret

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Bergougnoux

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P de Cremoux

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Milano

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

J-Y Pierga

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

16 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1765-1771

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20233745%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Circulating endothelial cells in oncology: pitfalls and promises

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ052

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43127349&oldid=2131777934"